HPGC Renmintongtai Pharmaceutical Corporation

¥8.66As of Sun 8 Nov 2026, 12:00 UTC
SSE:600829Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.80%)
Div yield —
ROE 5.16%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.12
PE TTM 31.66
TSR TTM 0.12%
Mkt cap ¥5.022B
ROIC 5.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.56
10.34%
(60.76%)
Hold 12|6|8|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.19
0.19
0.18
3.56%
13.24%
5.74%
0.18%
Revenue¥M
224.1
228.0
227.3
228.0
(3.81%)
(0.97%)
0.32%
(0.59%)
Peers (US$752.8M)
Cap (US$)
PE
776.3M
21.45x
755.8M
21.45x
Capital
TTM
5Y
10Y
Leveragex
3.420
0.043
0.041
EBIT/Intx
0.750
0.033
0.038
Own earn%
(28.66)
21.88
9.07
Sh yield%
29.13
37.20
35.71
Owners
Insiders/Inst%
2.72
85.55
Short interest%
2.49
SBC / revenue%
3.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
16–21
$1 testx
0.6
Incr. ROIC%
2